Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

  • Paolo Zanoni
  • Sumeet A Khetarpal
  • Daniel B Larach
  • William F Hancock-Cerutti
  • John S Millar
  • Marina Cuchel
  • Stephanie DerOhannessian
  • Anatol Kontush
  • Praveen Surendran
  • Danish Saleheen
  • Stella Trompet
  • J Wouter Jukema
  • Anton De Craen
  • Panos Deloukas
  • Naveed Sattar
  • Ian Ford
  • Chris Packard
  • Abdullah al Shafi Majumder
  • Dewan S Alam
  • Emanuele Di Angelantonio
  • Goncalo Abecasis
  • Rajiv Chowdhury
  • Jeanette Erdmann
  • Børge G Nordestgaard
  • Sune F Nielsen
  • Anne Tybjærg-Hansen
  • Ruth Frikke Schmidt
  • Kari Kuulasmaa
  • Dajiang J Liu
  • Markus Perola
  • Stefan Blankenberg
  • Veikko Salomaa
  • Satu Männistö
  • Philippe Amouyel
  • Dominique Arveiler
  • Jean Ferrieres
  • Martina Müller-Nurasyid
  • Marco Ferrario
  • Frank Kee
  • Cristen J Willer
  • Nilesh Samani
  • Heribert Schunkert
  • Adam S Butterworth
  • Joanna M M Howson
  • Gina M Peloso
  • Nathan O Stitziel
  • John Danesh
  • Sekar Kathiresan
  • Daniel J Rader
  • CHD Exome+ Consortium

Related Research units

Abstract

Scavenger receptor BI (SR-BI) is the major receptor for high-density lipoprotein (HDL) cholesterol (HDL-C). In humans, high amounts of HDL-C in plasma are associated with a lower risk of coronary heart disease (CHD). Mice that have depleted Scarb1 (SR-BI knockout mice) have markedly elevated HDL-C levels but, paradoxically, increased atherosclerosis. The impact of SR-BI on HDL metabolism and CHD risk in humans remains unclear. Through targeted sequencing of coding regions of lipid-modifying genes in 328 individuals with extremely high plasma HDL-C levels, we identified a homozygote for a loss-of-function variant, in which leucine replaces proline 376 (P376L), in SCARB1, the gene encoding SR-BI. The P376L variant impairs posttranslational processing of SR-BI and abrogates selective HDL cholesterol uptake in transfected cells, in hepatocyte-like cells derived from induced pluripotent stem cells from the homozygous subject, and in mice. Large population-based studies revealed that subjects who are heterozygous carriers of the P376L variant have significantly increased levels of plasma HDL-C. P376L carriers have a profound HDL-related phenotype and an increased risk of CHD (odds ratio = 1.79, which is statistically significant).

Bibliographical data

Original languageEnglish
ISSN0036-8075
DOIs
Publication statusPublished - 11.03.2016

Comment Deanary

Copyright © 2016, American Association for the Advancement of Science.

PubMed 26965621